The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mobile ECG Telemetry Device Market Research Report 2024
Synopsis
Mobile ECG telemetry equipment is an ECG diagnostic medical device that performs radio telemetry on human bioelectricity. It is easy to use and simple to operate, and realizes the measurement, monitoring, condition observation and data analysis of the vital signs of mobile patients.
Global Mobile ECG Telemetry Device market is projected to reach US$ 2163.7 million in 2029, increasing from US$ 942.7 million in 2022, with the CAGR of 11.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mobile ECG Telemetry Device market research.
Key manufacturers engaged in the Mobile ECG Telemetry Device industry include Applied Cardiac Systems Inc., Biotricity Inc., Medtronic plc, Preventice Solutions, Inc., Boston Scientific Corporation, BioTelemetry Inc., National Cardiac Inc., Telerhythmics LLC and The ScottCare Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Mobile ECG Telemetry Device were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mobile ECG Telemetry Device market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mobile ECG Telemetry Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Applied Cardiac Systems Inc.
Biotricity Inc.
Medtronic plc
Preventice Solutions, Inc.
Boston Scientific Corporation
BioTelemetry Inc.
National Cardiac Inc.
Telerhythmics LLC
The ScottCare Corporation
Medicomp Inc.
GE Healthcare
Philips Healthcare
Hemodynamics Company
Lifewatch
MidMark
Baxter
Spacelabs
Wuhan Mingde Biotechnology Co., Ltd.
Segment by Type
Wearable
Electronic SMD
Segment by Application
Hospital
Personal
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mobile ECG Telemetry Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Mobile ECG telemetry equipment is an ECG diagnostic medical device that performs radio telemetry on human bioelectricity. It is easy to use and simple to operate, and realizes the measurement, monitoring, condition observation and data analysis of the vital signs of mobile patients.
Global Mobile ECG Telemetry Device market is projected to reach US$ 2163.7 million in 2029, increasing from US$ 942.7 million in 2022, with the CAGR of 11.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mobile ECG Telemetry Device market research.
Key manufacturers engaged in the Mobile ECG Telemetry Device industry include Applied Cardiac Systems Inc., Biotricity Inc., Medtronic plc, Preventice Solutions, Inc., Boston Scientific Corporation, BioTelemetry Inc., National Cardiac Inc., Telerhythmics LLC and The ScottCare Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Mobile ECG Telemetry Device were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mobile ECG Telemetry Device market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mobile ECG Telemetry Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Applied Cardiac Systems Inc.
Biotricity Inc.
Medtronic plc
Preventice Solutions, Inc.
Boston Scientific Corporation
BioTelemetry Inc.
National Cardiac Inc.
Telerhythmics LLC
The ScottCare Corporation
Medicomp Inc.
GE Healthcare
Philips Healthcare
Hemodynamics Company
Lifewatch
MidMark
Baxter
Spacelabs
Wuhan Mingde Biotechnology Co., Ltd.
Segment by Type
Wearable
Electronic SMD
Segment by Application
Hospital
Personal
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mobile ECG Telemetry Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Mobile ECG Telemetry Device Market Overview
1.1 Product Overview and Scope of Mobile ECG Telemetry Device
1.2 Mobile ECG Telemetry Device Segment by Type
1.2.1 Global Mobile ECG Telemetry Device Market Value Comparison by Type (2023-2029)
1.2.2 Wearable
1.2.3 Electronic SMD
1.3 Mobile ECG Telemetry Device Segment by Application
1.3.1 Global Mobile ECG Telemetry Device Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Personal
1.3.4 Other
1.4 Global Mobile ECG Telemetry Device Market Size Estimates and Forecasts
1.4.1 Global Mobile ECG Telemetry Device Revenue 2018-2029
1.4.2 Global Mobile ECG Telemetry Device Sales 2018-2029
1.4.3 Global Mobile ECG Telemetry Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Mobile ECG Telemetry Device Market Competition by Manufacturers
2.1 Global Mobile ECG Telemetry Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Mobile ECG Telemetry Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Mobile ECG Telemetry Device Average Price by Manufacturers (2018-2023)
2.4 Global Mobile ECG Telemetry Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Mobile ECG Telemetry Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mobile ECG Telemetry Device, Product Type & Application
2.7 Mobile ECG Telemetry Device Market Competitive Situation and Trends
2.7.1 Mobile ECG Telemetry Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mobile ECG Telemetry Device Players Market Share by Revenue
2.7.3 Global Mobile ECG Telemetry Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mobile ECG Telemetry Device Retrospective Market Scenario by Region
3.1 Global Mobile ECG Telemetry Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Mobile ECG Telemetry Device Global Mobile ECG Telemetry Device Sales by Region: 2018-2029
3.2.1 Global Mobile ECG Telemetry Device Sales by Region: 2018-2023
3.2.2 Global Mobile ECG Telemetry Device Sales by Region: 2024-2029
3.3 Global Mobile ECG Telemetry Device Global Mobile ECG Telemetry Device Revenue by Region: 2018-2029
3.3.1 Global Mobile ECG Telemetry Device Revenue by Region: 2018-2023
3.3.2 Global Mobile ECG Telemetry Device Revenue by Region: 2024-2029
3.4 North America Mobile ECG Telemetry Device Market Facts & Figures by Country
3.4.1 North America Mobile ECG Telemetry Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Mobile ECG Telemetry Device Sales by Country (2018-2029)
3.4.3 North America Mobile ECG Telemetry Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mobile ECG Telemetry Device Market Facts & Figures by Country
3.5.1 Europe Mobile ECG Telemetry Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Mobile ECG Telemetry Device Sales by Country (2018-2029)
3.5.3 Europe Mobile ECG Telemetry Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mobile ECG Telemetry Device Market Facts & Figures by Country
3.6.1 Asia Pacific Mobile ECG Telemetry Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Mobile ECG Telemetry Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Mobile ECG Telemetry Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mobile ECG Telemetry Device Market Facts & Figures by Country
3.7.1 Latin America Mobile ECG Telemetry Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Mobile ECG Telemetry Device Sales by Country (2018-2029)
3.7.3 Latin America Mobile ECG Telemetry Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mobile ECG Telemetry Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Mobile ECG Telemetry Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Mobile ECG Telemetry Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Mobile ECG Telemetry Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mobile ECG Telemetry Device Sales by Type (2018-2029)
4.1.1 Global Mobile ECG Telemetry Device Sales by Type (2018-2023)
4.1.2 Global Mobile ECG Telemetry Device Sales by Type (2024-2029)
4.1.3 Global Mobile ECG Telemetry Device Sales Market Share by Type (2018-2029)
4.2 Global Mobile ECG Telemetry Device Revenue by Type (2018-2029)
4.2.1 Global Mobile ECG Telemetry Device Revenue by Type (2018-2023)
4.2.2 Global Mobile ECG Telemetry Device Revenue by Type (2024-2029)
4.2.3 Global Mobile ECG Telemetry Device Revenue Market Share by Type (2018-2029)
4.3 Global Mobile ECG Telemetry Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Mobile ECG Telemetry Device Sales by Application (2018-2029)
5.1.1 Global Mobile ECG Telemetry Device Sales by Application (2018-2023)
5.1.2 Global Mobile ECG Telemetry Device Sales by Application (2024-2029)
5.1.3 Global Mobile ECG Telemetry Device Sales Market Share by Application (2018-2029)
5.2 Global Mobile ECG Telemetry Device Revenue by Application (2018-2029)
5.2.1 Global Mobile ECG Telemetry Device Revenue by Application (2018-2023)
5.2.2 Global Mobile ECG Telemetry Device Revenue by Application (2024-2029)
5.2.3 Global Mobile ECG Telemetry Device Revenue Market Share by Application (2018-2029)
5.3 Global Mobile ECG Telemetry Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Applied Cardiac Systems Inc.
6.1.1 Applied Cardiac Systems Inc. Corporation Information
6.1.2 Applied Cardiac Systems Inc. Description and Business Overview
6.1.3 Applied Cardiac Systems Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Applied Cardiac Systems Inc. Mobile ECG Telemetry Device Product Portfolio
6.1.5 Applied Cardiac Systems Inc. Recent Developments/Updates
6.2 Biotricity Inc.
6.2.1 Biotricity Inc. Corporation Information
6.2.2 Biotricity Inc. Description and Business Overview
6.2.3 Biotricity Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Biotricity Inc. Mobile ECG Telemetry Device Product Portfolio
6.2.5 Biotricity Inc. Recent Developments/Updates
6.3 Medtronic plc
6.3.1 Medtronic plc Corporation Information
6.3.2 Medtronic plc Description and Business Overview
6.3.3 Medtronic plc Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic plc Mobile ECG Telemetry Device Product Portfolio
6.3.5 Medtronic plc Recent Developments/Updates
6.4 Preventice Solutions, Inc.
6.4.1 Preventice Solutions, Inc. Corporation Information
6.4.2 Preventice Solutions, Inc. Description and Business Overview
6.4.3 Preventice Solutions, Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Preventice Solutions, Inc. Mobile ECG Telemetry Device Product Portfolio
6.4.5 Preventice Solutions, Inc. Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boston Scientific Corporation Mobile ECG Telemetry Device Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 BioTelemetry Inc.
6.6.1 BioTelemetry Inc. Corporation Information
6.6.2 BioTelemetry Inc. Description and Business Overview
6.6.3 BioTelemetry Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BioTelemetry Inc. Mobile ECG Telemetry Device Product Portfolio
6.6.5 BioTelemetry Inc. Recent Developments/Updates
6.7 National Cardiac Inc.
6.6.1 National Cardiac Inc. Corporation Information
6.6.2 National Cardiac Inc. Description and Business Overview
6.6.3 National Cardiac Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 National Cardiac Inc. Mobile ECG Telemetry Device Product Portfolio
6.7.5 National Cardiac Inc. Recent Developments/Updates
6.8 Telerhythmics LLC
6.8.1 Telerhythmics LLC Corporation Information
6.8.2 Telerhythmics LLC Description and Business Overview
6.8.3 Telerhythmics LLC Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Telerhythmics LLC Mobile ECG Telemetry Device Product Portfolio
6.8.5 Telerhythmics LLC Recent Developments/Updates
6.9 The ScottCare Corporation
6.9.1 The ScottCare Corporation Corporation Information
6.9.2 The ScottCare Corporation Description and Business Overview
6.9.3 The ScottCare Corporation Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 The ScottCare Corporation Mobile ECG Telemetry Device Product Portfolio
6.9.5 The ScottCare Corporation Recent Developments/Updates
6.10 Medicomp Inc.
6.10.1 Medicomp Inc. Corporation Information
6.10.2 Medicomp Inc. Description and Business Overview
6.10.3 Medicomp Inc. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medicomp Inc. Mobile ECG Telemetry Device Product Portfolio
6.10.5 Medicomp Inc. Recent Developments/Updates
6.11 GE Healthcare
6.11.1 GE Healthcare Corporation Information
6.11.2 GE Healthcare Mobile ECG Telemetry Device Description and Business Overview
6.11.3 GE Healthcare Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GE Healthcare Mobile ECG Telemetry Device Product Portfolio
6.11.5 GE Healthcare Recent Developments/Updates
6.12 Philips Healthcare
6.12.1 Philips Healthcare Corporation Information
6.12.2 Philips Healthcare Mobile ECG Telemetry Device Description and Business Overview
6.12.3 Philips Healthcare Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Philips Healthcare Mobile ECG Telemetry Device Product Portfolio
6.12.5 Philips Healthcare Recent Developments/Updates
6.13 Hemodynamics Company
6.13.1 Hemodynamics Company Corporation Information
6.13.2 Hemodynamics Company Mobile ECG Telemetry Device Description and Business Overview
6.13.3 Hemodynamics Company Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hemodynamics Company Mobile ECG Telemetry Device Product Portfolio
6.13.5 Hemodynamics Company Recent Developments/Updates
6.14 Lifewatch
6.14.1 Lifewatch Corporation Information
6.14.2 Lifewatch Mobile ECG Telemetry Device Description and Business Overview
6.14.3 Lifewatch Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lifewatch Mobile ECG Telemetry Device Product Portfolio
6.14.5 Lifewatch Recent Developments/Updates
6.15 MidMark
6.15.1 MidMark Corporation Information
6.15.2 MidMark Mobile ECG Telemetry Device Description and Business Overview
6.15.3 MidMark Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MidMark Mobile ECG Telemetry Device Product Portfolio
6.15.5 MidMark Recent Developments/Updates
6.16 Baxter
6.16.1 Baxter Corporation Information
6.16.2 Baxter Mobile ECG Telemetry Device Description and Business Overview
6.16.3 Baxter Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Baxter Mobile ECG Telemetry Device Product Portfolio
6.16.5 Baxter Recent Developments/Updates
6.17 Spacelabs
6.17.1 Spacelabs Corporation Information
6.17.2 Spacelabs Mobile ECG Telemetry Device Description and Business Overview
6.17.3 Spacelabs Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Spacelabs Mobile ECG Telemetry Device Product Portfolio
6.17.5 Spacelabs Recent Developments/Updates
6.18 Wuhan Mingde Biotechnology Co., Ltd.
6.18.1 Wuhan Mingde Biotechnology Co., Ltd. Corporation Information
6.18.2 Wuhan Mingde Biotechnology Co., Ltd. Mobile ECG Telemetry Device Description and Business Overview
6.18.3 Wuhan Mingde Biotechnology Co., Ltd. Mobile ECG Telemetry Device Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Wuhan Mingde Biotechnology Co., Ltd. Mobile ECG Telemetry Device Product Portfolio
6.18.5 Wuhan Mingde Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mobile ECG Telemetry Device Industry Chain Analysis
7.2 Mobile ECG Telemetry Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mobile ECG Telemetry Device Production Mode & Process
7.4 Mobile ECG Telemetry Device Sales and Marketing
7.4.1 Mobile ECG Telemetry Device Sales Channels
7.4.2 Mobile ECG Telemetry Device Distributors
7.5 Mobile ECG Telemetry Device Customers
8 Mobile ECG Telemetry Device Market Dynamics
8.1 Mobile ECG Telemetry Device Industry Trends
8.2 Mobile ECG Telemetry Device Market Drivers
8.3 Mobile ECG Telemetry Device Market Challenges
8.4 Mobile ECG Telemetry Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
